Evaluate

Evaluate is an IT company that provides commercial intelligence and predictive analytics solutions to the pharmaceutical industry. Read more

976 Followers on Owler
976 Followers on Owler
976 Followers on Owler
976 Followers on Owler

Evaluate

Evaluate is an IT company that provides commercial intelligence and predictive analytics solutions to the pharmaceutical industry. Read more

Deborah Kobewka's photo - CEO of Evaluate

CEO

Deborah Kobewka

CEO Approval Rating

82/100

Founded:

1996

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

EVALUATE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BioXcel is a top competitor of Evaluate. BioXcel was founded in 2005, and is headquartered in Branford, Connecticut. Like Evaluate, BioXcel also competes in the Analytics field. BioXcel generates $26.7M less revenue vs. Evaluate.

Domino is seen as one of Evaluate's top competitors. Domino is headquartered in San Francisco, California, and was founded in 2013. Like Evaluate, Domino also operates in the Analytics field. Domino generates 39% the revenue of Evaluate.

RapidMiner has been one of Evaluate's top competitors. RapidMiner's headquarters is in Boston, Massachusetts, and was founded in 2007. Like Evaluate, RapidMiner also works within the Analytics industry. RapidMiner generates 64% of Evaluate's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 170 a good estimate for Evaluate's Employee count?

Evaluate Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Bioscience Advisors, Inc.

May 2021

Source »
undisclosed
Biosci is a California-based data and consulting business that provides commercial intelligence and analysis for the biopharma industry.

These are all the companies that Evaluate has acquired. Evaluate's latest acquisition was Bioscience Advisors, Inc. in May 2021. Biosci is a California-based data and consulting business that provides commercial intelligence and analysis for the biopharma industry.

Evaluate Funding History

Since Evaluate was founded in 1996, it has participated in 2 rounds of funding. In total Evaluate has raised $10.6M. Evaluate's last funding round was on Aug 2020 for a total of $10.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Equity Round
Aug 2020
$10.6M

HgCapital

Equity
Nov 2016
--

Since Evaluate was founded in 1996, it has participated in 2 rounds of funding. In total Evaluate has raised $10.6M. Evaluate's last funding round was on Aug 2020 for a total of $10.6M

Evaluate Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Advera Health is an informatics company that provides data and insights for healthcare decision makers.
$2M
Apr 15, 2014
Series A
-

These are all the companies that Evaluate has invested in. Evaluate's latest investment was Bioscience Advisors, Inc. in May 2021. Biosci is a California-based data and consulting business that provides commercial intelligence and analysis for the biopharma industry.

Evaluate News

April 1, 2020FinSMEs

Evaluate Acquires Black Swan Analysis

Evaluate Ltd., a London, UK-based provider of...... See more »
December 16, 2019CFO MOVES

Evaluate Ltd. [LONDON & BOSTON & TOKYO] announced the appointment of Martyn Hindley as Chief Financial Officer

Evaluate Ltd. [LONDON & BOSTON & TOKYO] announced the appointment of Martyn Hindley as Chief Financia... See more »
August 6, 2019BioPortfolio

Evaluate launches success assessment platform for drug developers

Product Specific PTRS Evaluates machine learning platform aims to help assess the likelihood of a dru... See more »
August 5, 20194-traders

transforms pharma R&D risk assessment with launch of Product Specific PTRS

(marketscreener.com) Breakthrough offering combines the power of machine learning with the transparen... See more »
June 4, 2019BioPortfolio

Innovation and Unmet Need Drive Prescription Drug Sales to $1.18tr by 2024 New Report from Evaluate Ltd

EvaluatePharma World Preview 2019 Outlook to 2024 explores growth drivers growth brakes and top indu... See more »
June 6, 20184-traders

Worldwide prescription drug sales accelerate to $1.2 trillion by 2024, as unmet need drives annual compound growth to over 6%

(4-traders.com) Eleventh annual EvaluatePharma® World Preview 2018, Outlook to 2024 report launches a... See more »

Evaluate Press Releases

December 19, 2019Business Wire

Strong Sales and Product Launches Set the Stage for Biopharma Growth, but Underlying Market Concerns Exist

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)-- #biopharma--Oncology dominates the growth outlook for phar... See more »
May 29, 2018StreetInsider

Worldwide Orphan Drug Sales Are Forecast to Grow at a CAGR of 11.3% from 2018 to 2024, Double the Rate Forecast for the Non-Orphan Drug Market

Continuing unmet medical need is set to fuel the growth of the worldwide orphan drug market, with sal... See more »
July 20, 2017Blackbird

Blockbusters Out, Highly Targeted Therapies In

LONDON & BOSTON & SAN FRANCISCO & TOKYO-(BUSINESS WIRE)-Today life science commercial intelligence le... See more »
February 21, 2017Business Wire

EP Vantage Releases its Annual Pharma and Medtech Sector Review Reports for 2016

LONDON, BOSTON, SAN FRANCISCO & TOKYO--(BUSINESS WIRE)--EP Vantage Releases its Annual Pharma and Med... See more »
January 25, 2017Business Wire

The Value of Outliers in Consensus Forecasting

LONDON, BOSTON, SAN FRANCISCO & TOKYO--(BUSINESS WIRE)--Evaluate Ltd releases the first of a series o... See more »
December 8, 2016Blackbird

Higher M&A Activity and Investor Cash Expected to Re-invigorate Pharma and Biotech in 2017

LONDON & BOSTON & SAN FRANCISCO & TOKYO-(BUSINESS WIRE)-Despite the uncertainty that loomed over the ... See more »

Social Media

Evaluate Headquarters

11-29 Fashion Street

London, EnglandE1 6PX

0-20-7377-0800

Driving Directions »

Trending Companies

Evaluate Summary

ABOUT

Overview

Evaluate is an IT company that provides commercial intelligence and predictive analytics solutions to the pharmaceutical industry. Evaluate was founded in 1996. Evaluate's headquarters is located in London, England, GB E1 6PX. It has raised 10.6M in 2...

CEO

Evaluate's CEO, Deborah Kobewka, currently has an approval rating of 82%. Evaluate's primary competitors are BioXcel, Domino & RapidMiner.

Website

evaluategroup.com

Frequently Asked Questions about Evaluate

  1. When was Evaluate founded?

    Evaluate was founded in 1996
  2. Who is Evaluate's CEO?

    Evaluate's CEO is Deborah Kobewka
  3. How much revenue does Evaluate generate?

    Evaluate generates $29.6M in revenue
  4. How much funding does Evaluate have?

    Evaluate has historically raised $10.6M in funding
  5. Where is Evaluate's headquarters?

    Evaluate's headquarters is in London England, GB
  1. How many employees does Evaluate have?

    Evaluate has 170 employees
  2. What sector does Evaluate operate in?

    Evaluate is in Analytics
  3. Who are Evaluate's competitors?

    Evaluate's top competitors are BioXcel, Domino, RapidMiner
  4. Who has Evaluate invested in?

    Evaluate's has invested in companies such as Advera Health Analytics